From: Target enrichment using parallel nanoliter quantitative PCR amplification
Samples | Mutations: | ||||
---|---|---|---|---|---|
Name | Type | Gene name | Genomic location | cDNA position | Protein position |
BT-549 | Breast cancer cell line | PTEN | 10:89720672 | c.823delG | p.V275fs*1 |
CCRF-CEM | Leukemia cancer cell ine | CDKN2A | 9:21968228 | c.1_471del471 | |
9:21971002 | c.317_522del206 | ||||
MLH1 | 3:37042536 | c.298C > T | p.R100* | ||
3:37056036 | c.790 + 1G > A | ||||
NOTCH1 | 9:139399362 | c.4783_4784ins36 | p.R1595 > PRLPHNSSFHFLR | ||
PTEN | 10:89653782 | c.80_492del413 | |||
HCT116 | Colon cancer cell line | CDKN2A | 9:21974758 | c.68_69insG | p.R24fs*20 |
9:21994234 | c.220_220delG | p.E74fs*15 | |||
MLH1 | 3:37056000 | c.755C > A | p.S252* | ||
IGROV-1 | Ovarian cancer cell ine | MLH1 | 3:37070378 | c.1513delA | p.S505fs*3 |
MSH6 | 2:48030647 | c.3261delC | p.F1088fs*2 | ||
PC3 | Prostate cancer cell line | PTEN | 10:89685270 | c.165_1212del1048 | p.R55fs*1 |
SN12C | Kidney cancer cell line | NF2 | 22:30032739 | c.115-1G > C | |
786-O | Kidney cancer cell line | CDKN2A | 9:21974677 | c.1_150del150 | |
9:21984138-21984453 | c.1_316del316 | ||||
PTEN | 10:89692961 | c.445C > T | p.Q149* | ||
VHL | 3:10183842 | c.311delG | p.G104fs*55 | ||
ACHN | Kidney cancer cell line | CDKN2A | 9:21968228 | c.1_471del471 | |
9:21971002 | c.317_522del206 | ||||
NF2 | 22:30032794 | c.169C > T | p.R57* | ||
DU-145 | Prostate cancer cell line | CDKN2A | 9:21971108 | c.250G > T | p.D84Y |
MLH1 | 3:37038108 | c.117-2A > T | |||
HCT-15 | Colon cancer cell line | APC | 5:112177787 | c.6496C > T | p.R2166* |
5:112175539 | c.4248delC | p.I1417fs*2 | |||
BRCA2 | 13:32913837 | c.5351delA | p.N1784fs*7 | ||
13:32913837 | c.3599_3600delGT | p.C1200fs*1 | |||
MSH6 | 2:48032121 | c.3511_3516 > T | p.D1171fs*4 | ||
2:48025990 | c.868delC | p.L290fs*1 | |||
HT-29 | Colon cancer cell line | APC | 5:112173848 | c.2557G > T | p.E853* |
5:112175957 | c.4666_4667insA | p.T1556fs*3 | |||
MCF7 | Breast cancer cell line | CDKN2A | 9:21971002 | c.317_522del206 | |
9:21968228 | c.1_471del471 | ||||
MDA-MB-231 | Breast cancer cell line | CDKN2A | 9:21967751 | c.1_522del522 | |
9:21968228 | c.1_471del471 | ||||
NF2 | 22:30057209 | c.691G > T | p.E231* | ||
MOLT-4 | Leukemia cancer cell line | CDKN2A | 9:21967751 | c.1_522del522 | |
9:21968228 | c.1_471del471 | ||||
NOTCH1 | 9:139390649 | c.7544_7545delCT | p.P2515fs*4 | ||
PTEN | 10:89717775. | c.800delA | p.K267fs*9 | ||
OVCAR-5 | Ovarian cancer cell line | CDKN2A | 9:21967751 | c.1_522del522 | |
9:21968228 | c.1_471del471 | ||||
Normal1 | Healthy normal1 control DNA | ||||
Normal2 | Healthy normal2 control DNA |